Showing 731-740 of 6983 results for "".
Take 5: Recent Findings in Acne Research
https://practicaldermatology.com/columns/take-5/take-5-recent-findings-in-acne-research/21733/Five new studies examine potentially useful therapies and strategies to improve adherence.Thin Melanomas: When is SLN Biopsy Indicated?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thin-melanomas-when-is-sln-biopsy-indicated/20805/New research offers additional evidence that mitotic rate may have a role in clinical decision-making.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muCare for Skin of Color: Hope on the Horizon
https://practicaldermatology.com/topics/skin-cancer-photoprotection/care-for-skin-of-color-hope-on-the-horizon/20562/Experts address new and emerging options to treat a growing patient population in the US.Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/21265/Atypical Sweet Syndrome: A Case Report and Brief Literature Review
https://practicaldermatology.com/topics/rare-disease/atypical-sweet-syndrome-a-case-report-and-brief-literature-review/23610/A case highlights the complexity of this diagnosis, including its management and workup, especially when pathology findings are atypical.Is Irritable Bowel Linked to Irritable Skin?
https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/Exploring irritable bowel syndrome’s link to dermatologic conditions.Unpacking the Latest CMS Proposal
https://practicaldermatology.com/topics/practice-management/unpacking-the-latest-cms-proposal/20349/What might these changes mean for dermatologists?BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianAntioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.